Shien Guo

机构：Fujian Electric Power Survey & Design Institute, Thermo Fisher Scientific (United States)

发表论文 96 篇 · 总被引 1140 次 · h-index 20

代表论文

• Health-related quality of life with idecabtagene vicleucel in relapsed and refractory multiple myeloma (2021 · Blood Advances · 被引 65)
• Health-related quality of life in patients with triple-class exposed relapsed and refractory multiple myeloma treated with idecabtagene vicleucel or standard regimens: patient-reported outcomes from the phase 3, randomised, open-label KarMMa-3 clinical trial (2024 · The Lancet Haematology · 被引 27)
• Health-related quality of life with lisocabtagene maraleucel vs standard of care in relapsed or refractory LBCL (2022 · Blood Advances · 被引 23)
• Health-Related Quality of Life Outcomes in Patients with Myelodysplastic Syndromes with Ring Sideroblasts Treated with Luspatercept in the MEDALIST Phase 3 Trial (2021 · Journal of Clinical Medicine · 被引 23)
• Esketamine versus placebo on time to remission in major depressive disorder with acute suicidality (2023 · BMC Psychiatry · 被引 22)
• Health-related quality of life with nivolumab plus relatlimab versus nivolumab monotherapy in patients with previously untreated unresectable or metastatic melanoma: RELATIVITY-047 trial (2023 · European Journal of Cancer · 被引 20)